These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3895171)

  • 21. Multicenter study of bitolterol and isoproterenol nebulizer solutions in nonsteroid-using patients.
    Pinnas JL; Bernstein IL; Bronsky EE; Bush RK; Chervinsky P; Condemi JJ; Dockhorn RJ; Nathan RA; Repsher LH; Bhatt BD
    J Allergy Clin Immunol; 1987 May; 79(5):768-75. PubMed ID: 3571768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of inhaled formoterol in the treatment of asthma.
    Berger WE
    Ann Allergy Asthma Immunol; 2006 Jul; 97(1):24-33. PubMed ID: 16892777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Life-threatening asthma during treatment with salmeterol.
    Weinberger M; Abu-Hasan M
    N Engl J Med; 2006 Aug; 355(8):852-3. PubMed ID: 16929006
    [No Abstract]   [Full Text] [Related]  

  • 24. Long acting beta-agonists versus theophylline for maintenance treatment of asthma.
    Wilson AJ; Gibson PG; Coughlan J
    Cochrane Database Syst Rev; 2000; (2):CD001281. PubMed ID: 10796631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comments of the German Airway League and the German Respiratory Society to the US Food and Drug Administration (FDA)'s announcement from February 18th 2010 on the use of long acting beta-2 agonists in treatment of asthma].
    Kardos P; Berdel D; Buhl R; Criée CP; Freihorst J; Gillissen A; Karg O; Pfeifer M; Magnussen H; Rabe KF; Teschler H; Vogelmeier C; Welte T; Wettengel R; Worth H
    Pneumologie; 2010 Jun; 64(6):333-5. PubMed ID: 20533125
    [No Abstract]   [Full Text] [Related]  

  • 26. Multicenter dose-ranging study of bitolterol mesylate solution for nebulization in children with asthma.
    Nathan RA; Bronsky EA; Dockhorn RJ; Kemp JP
    Ann Allergy; 1994 Mar; 72(3):209-16. PubMed ID: 8129213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Long acting beta-2 agonists. Discussion of their use in asthma].
    Aumiller J
    MMW Fortschr Med; 2009 Apr; 151(15):14. PubMed ID: 19728671
    [No Abstract]   [Full Text] [Related]  

  • 28. Salmeterol and formoterol: asthma aggravation. Use should be restricted.
    Prescrire Int; 2009 Aug; 18(102):166. PubMed ID: 19743580
    [No Abstract]   [Full Text] [Related]  

  • 29. Budesonide + formoterol: new dose regimen. Asthma attacks: a step backwards.
    Prescrire Int; 2008 Apr; 17(94):57. PubMed ID: 18516807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of salbutamol and bitolterol mesilate on pO2 levels in asthmatic patients and healthy volunteers.
    Dal Negro R; Cogo AL; Pomari C; Turati C; Turco P; Allegra L
    Arzneimittelforschung; 1992 Jul; 42(7):959-61. PubMed ID: 1418062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nocturnal asthma therapy. Inhaled bitolterol versus sustained-release theophylline.
    Zwillich CW; Neagley SR; Cicutto L; White DP; Martin RJ
    Am Rev Respir Dis; 1989 Feb; 139(2):470-4. PubMed ID: 2643904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bronchodilator effect of single-dose formoterol administered by pressurized metered-dose inhaler in children with asthma aged 6 to <12 years receiving budesonide.
    Berger WE; Gillen M; Eckerwall G; Uryniak T; Trudo FJ; Lampl KL
    Allergy Asthma Proc; 2014; 35(2):134-40. PubMed ID: 24717790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A clinical and spirometric trial of a new receptor stimulant drug, terbutaline, in asthmaic patients.
    Linehan WD
    Ir J Med Sci; 1973 May; 142(3):115-22. PubMed ID: 4145794
    [No Abstract]   [Full Text] [Related]  

  • 34. State of the art in beta2-agonist therapy: a safety review of long-acting agents.
    Rabe KF
    Int J Clin Pract; 2003 Oct; 57(8):689-97. PubMed ID: 14627180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of formoterol for the treatment of chronic obstructive pulmonary disease.
    Berger WE; Nadel JA
    Respir Med; 2008 Feb; 102(2):173-88. PubMed ID: 18023995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mometasone furoate/formoterol in the treatment of persistent asthma.
    Berger WE
    Expert Rev Respir Med; 2011 Dec; 5(6):739-46. PubMed ID: 22082160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhaled corticosteroid therapy in asthma: a balancing act.
    Li JT
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):229-30. PubMed ID: 10094213
    [No Abstract]   [Full Text] [Related]  

  • 38. Eformoterol and bronchial hyperresponsiveness in mild asthma.
    Chung KF
    Br J Clin Pract Suppl; 1995 Sep; 81():14-5. PubMed ID: 8546888
    [No Abstract]   [Full Text] [Related]  

  • 39. Fluticasone/Formoterol combination therapy compared with monotherapy in adolescent and adult patients with mild to moderate asthma.
    Pearlman DS; LaForce CF; Kaiser K
    Clin Ther; 2013 Jul; 35(7):950-66. PubMed ID: 23870606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of fluticasone/formoterol combination therapy in patients with moderate-to-severe asthma.
    Corren J; Mansfield LE; Pertseva T; Blahzko V; Kaiser K
    Respir Med; 2013 Feb; 107(2):180-95. PubMed ID: 23273405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.